Chargement en cours...
Clofazimine-Containing Regimen for the Treatment of Mycobacterium abscessus Lung Disease
Patients with lung disease caused by Mycobacterium abscessus subsp. abscessus (here M. abscessus) typically have poor treatment outcomes. Although clofazimine (CFZ) has been increasingly used in the treatment of M. abscessus lung disease in clinical practice, there are no reported data on its effect...
Enregistré dans:
| Publié dans: | Antimicrob Agents Chemother |
|---|---|
| Auteurs principaux: | , , , , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society for Microbiology
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5444135/ https://ncbi.nlm.nih.gov/pubmed/28348153 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.02052-16 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|